Evaluation and Prognostication of Gd‐EOB‐DTPA MRI and CT in Patients With Macrotrabecular‐Massive Hepatocellular Carcinoma
Journal of Magnetic Resonance Imaging · 2024
DOI: 10.1002/jmri.29052 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Magnetic Resonance Imaging, 2024. Verfasst von Jie Cheng und 13 weiteren Autor:innen. Beteiligte Einrichtung: Department of Radiology, Southwest Hospital, Third Military Medical University (Army Medical University), Chongqing, China. Hauptthemen laut MEDLINE: Liver Neoplasms, Gadolinium DTPA, Magnetic Resonance Imaging, Carcinoma, Hepatocellular. Die Arbeit wurde bisher 13-mal zitiert (Crossref) und nennt 39 Literaturangaben. Gefördert von: National Natural Science Foundation of Chongqing.
Abstract (Originalsprache)
Background
Macrotrabecular‐massive hepatocellular carcinoma (MTM‐HCC) is highly aggressive. Comparing the diagnosis ability of CT and gadoxetate disodium (Gd‐EOB‐DTPA) MRI for MTM‐HCC are lacking.
Purpose
To compare the performance of Gd‐EOB‐DTPA MRI and CT for differentiating MTM‐HCC from non‐MTM‐HCC, and determine the prognostic indicator. Study Type Retrospective. Subjects Post‐surgery HCC patients, divided into the training (N = 272) and external validation (N = 44) cohorts. Field Strength/Sequence 3.0 T, T1‐weighted imaging, in‐opp phase, and T1‐weighted volumetric interpolated breath‐hold examination/liver acquisition with volume acceleration; enhanced CT. Assessment Three radiologists evaluated clinical characteristics (sex, age, liver disease, liver function, blood routine, alpha‐fetoprotein [AFP] and prothrombin time international normalization ratio [PT‐INR]) and imaging features (tumor length, intratumor fat, hemorrhage, arterial phase peritumoral enhancement, intratumor necrosis or ischemia, capsule, and peritumoral hepatobiliary phase [HBP] hypointensity). Compared the performance of CT and MRI for diagnosing MTM‐HCC. Follow‐up occurred every 3–6 months, and nomogram demonstrated the probability of MTM‐HCC. Statistical Tests Fisher test, t ‐test or Wilcoxon rank‐sum test, area under the curve (AUC), 95% confidence interval (CI), multivariable logistic regression, Kaplan–Meier curve, and Cox proportional hazards. Significance level: P < 0.05.
Results
Gd‐EOB‐DTPA MRI (AUC: 0.793; 95% CI, 0.740–0.839) outperformed CT (AUC: 0.747; 95% CI, 0.691–0.797) in the training cohort. The nomogram, incorporating AFP, PT‐INR, and MRI features (non‐intratumor fat, incomplete capsule, intratumor necrosis or ischemia, and peritumoral HBP hypointensity) demonstrated powerful performance for diagnosing MTM‐HCC with an AUC of 0.826 (95% CI, 0.631–1.000) in the external validation cohort. Median follow‐up was 347 days (interquartile range [IQR], 606 days) for the training cohort and 222 days (IQR, 441 days) for external validation cohort. Intratumor necrosis or ischemia was an independent indicator for poor prognosis. Data Conclusion Gd‐EOB‐DTPA MRI might assist in preoperative diagnosis of MTM‐HCC, and intratumor necrosis or ischemia was associated with poor prognosis. Evidence Level 4 Technical Efficacy Stage 2
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Radiology, Southwest Hospital, Third Military Medical University (Army Medical University), Chongqing, China.
- 7T Magnetic Resonance Imaging Translational Medical Center, Southwest Hospital, Army Medical University (Third Military Medical University), Chongqing, China.
- Department of Radiology, The Third Affiliated Hospital of Chongqing Medical University, Chongqing, China.
- Institute of Pathology and Southwest Cancer Center, Southwest Hospital, Third Military Medical University (Army Medical University), Chongqing, China.
- School of Medical Imaging, North Sichuan Medical College, Nanchong, China.
ORCID-Profile: Jie Cheng, Xiaofeng Li, Limei Wang, Fengxi Chen, Yiman Li, Guojiao Zuo, Mi Pei, Huarong Zhang, Linze Yu, Chen Liu, Jian Wang, Qi Han, Ping Cai, Xiaoming Li
Förderung
- National Natural Science Foundation of Chongqing
Zitieren
APA
Cheng, J., Li, X., Wang, L., Chen, F., Li, Y., Zuo, G., Pei, M., Zhang, H., Yu, L., Liu, C., Wang, J., Han, Q., Cai, P., & Li, X. (2024). Evaluation and Prognostication of Gd‐EOB‐DTPA MRI and CT in Patients With Macrotrabecular‐Massive Hepatocellular Carcinoma. Journal of Magnetic Resonance Imaging. https://doi.org/10.1002/jmri.29052
Vancouver
Cheng J, Li X, Wang L, Chen F, Li Y, Zuo G, et al. Evaluation and Prognostication of Gd‐EOB‐DTPA MRI and CT in Patients With Macrotrabecular‐Massive Hepatocellular Carcinoma. Journal of Magnetic Resonance Imaging. 2024. doi:10.1002/jmri.29052
BibTeX
@article{Cheng2024,
author = {Cheng, Jie and Li, Xiaofeng and Wang, Limei and Chen, Fengxi and Li, Yiman and Zuo, Guojiao and Pei, Mi and Zhang, Huarong and Yu, Linze and Liu, Chen and Wang, Jian and Han, Qi and Cai, Ping and Li, Xiaoming},
title = {Evaluation and Prognostication of Gd‐EOB‐DTPA MRI and CT in Patients With Macrotrabecular‐Massive Hepatocellular Carcinoma},
journal = {Journal of Magnetic Resonance Imaging},
year = {2024},
doi = {10.1002/jmri.29052}
}
EUVIMED